Alex Zhavoronkov, PhD presents at PEGS Boston (IMAGE)

InSilico Medicine

Alex Zhavoronkov, PhD presents at PEGS Boston

Caption

Dr. Zhavoronkov will make the first announcement of peptide-based drug design strategies and Generative Biologics, a new engine that belongs to the company's end-to-end AI-driven drug discovery platform, Pharma.AI.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.